Alland Leila

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$51,799.00
Insider Sells Quantity
9
Insider Sells Sum
$1.16M

Insider Activity of Alland Leila

According to the SEC Form 4 filings, Alland Leila, being in a position of

  1. director at Abeona Therapeutics Inc.,
    оver the last 12 months, has bought 11000 shares for $51,799, and sold 0 shares,
    over all time since 2023-09-27, has bought 11000 shares for $51,799, and sold 7246 shares for $28,270.

The largest purchase of all time was on 2024-05-16 and amounted to 11000 shares of Abeona Therapeutics Inc. for $51,799.

The largest sale of all time was on 2021-05-07 and amounted to 8000 shares of PMV Pharmaceuticals, Inc. for $278,618.

Biography of Alland Leila

No biography is available at this moment.

2024-05-16PurchaseAbeona Therapeutics Inc.
ABEO
director
11,000
0.0286%
$4.71$51,799+20.78%
2023-09-27SaleAbeona Therapeutics Inc.
ABEO
director
7,246
0.0288%
$3.90$28,270+20.96%
2023-09-15SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
6,291
0.0128%
$6.62$41,646-73.47%
2021-09-09SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
100
0.0002%
$30.25$3,025-40.96%
2021-09-07SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
3,900
0.009%
$30.25$117,975-40.85%
2021-08-09SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
4,471
0.0095%
$34.04$152,202-46.87%
2021-07-07SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
4,000
0.0088%
$32.30$129,213-32.29%
2021-06-07SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
4,000
0.0089%
$33.60$134,387-30.42%
2021-05-07SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
8,000
0.0177%
$34.83$278,618-30.86%
2021-04-07SalePMV Pharmaceuticals, Inc.
PMVP
Chief Medical Officer
8,000
0.0178%
$33.86$270,889-19.47%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.